] i signaling in HMEC, suggesting that G␤␥ derived from G o but not G i could activate PLC␤. The involvement of G o proteins on events downstream from calcium signaling was further evidenced by investigating the effect of G o1 minigenes on thrombin-stimulated stress fiber formation and endothelial barrier permeability. Both of these effects were sensitive to pertussis toxin treatment and could be blocked by transfection of G o1 minigenes but not G i1/2 minigenes. We conclude that the G o proteins play a role in thrombin signaling distinct from G i1/2 proteins, which are mediated through their G␤␥ subunits and involve coupling to calcium signaling and cytoskeletal rearrangements.
Thrombin is a multifunctional serine protease that catalyzes conversion of fibrinogen to fibrin, a process that is crucial in blood coagulation (1) . In addition, thrombin plays a central role in a variety of biological functions such as platelet aggregation, mitogenesis of fibroblasts, monocytic cell chemotaxis, and endothelial cell monolayer permeability (2) (3) (4) . Many of its actions, including the regulation of biochemical, transcriptional, and functional responses in endothelial cells occur through activation of protease-activated receptors (PARs), 1 which belong to the superfamily of G protein-coupled receptors.
Four PARs have been cloned so far, but only PAR1, PAR3, and PAR4 can be activated by thrombin (5) . The activation and signal transduction pathways of PAR1, the prototype of the PAR family, have been studied in great detail. Thrombin cleaves the N-terminal extracellular domain of PAR1 at a specific site, which unmasks a new N terminus that then serves as a tethered agonist ligand and activates the receptor by binding intramolecularly to the body of the receptor (6) . Cleaved, i.e. irreversibly activated, PAR1 can couple to members of the G i/o , G q , and G 12/13 protein families and regulate a variety of intracellular effectors (1) .
Although the role of G o proteins has been generally believed to be confined to the brain and heart, several reports indicate that G o proteins may serve to regulate various intracellular pathways in non-neuronal cell lines (7, 8) . In addition, several new effectors have been identified that are specifically or differentially regulated by G o proteins (versus G i proteins) (9 -11) . Pertussis toxin (PTX)-mediated ADP-ribosylation of the Cys 351 residue in the C terminus of G i and G o proteins disables their interaction with receptors and thus prevents receptor-mediated activation of these G proteins. Many effects of thrombin are mediated through pertussis toxin-sensitive G proteins (12) (13) (14) (15) (16) (17) (18) . This method, however, does not distinguish between G i and G o proteins, and the importance of the latter subtype could be inadequately appreciated (5) .
To dissect out the contribution of G i1/2 and G o1 proteins in thrombin-regulated signaling pathways in HMECs, we have designed a dominant negative strategy based on minigene vectors that encode the C-terminal 11-amino acid sequence from G␣. Previously, we have shown that these minigenes are quite specific in such a way that G q -based minigenes blocked only thrombin activation of G q protein-mediated pathways (phos-phatidylinositol bisphosphate hydrolysis and intracellular calcium increase) but not G i1/2 or G 12/13 protein-mediated pathways (1, 19) . The specificity of G␣ C-terminal peptides has been shown dramatically by Gilchrist et al. (20) , where one or two amino acid substitutions inhibited the ability of peptides to block receptor-mediated activation of signaling pathways.
To delineate specific functions for G i and G o proteins in the signaling of thrombin receptors, we have introduced these minigenes into HMECs. Our findings indicate that HMECs contain G o proteins and that PAR1 has the potential to couple to G i and G o proteins when co-expressed in Sf 9 cell membranes. In addition, we show that G o1 minigenes block thrombin-stimulated release of [Ca 2ϩ ] i , whereas G i1/2 minigenes do not. The involvement of G o proteins, but not G i proteins, was further established in pathways that are known to be downstream of calcium signaling, such as stress fiber formation and endothelial barrier permeability. Together our data demonstrate the importance of G o proteins in the signaling of thrombin receptors in endothelial cells.
MATERIALS AND METHODS
Reagents-All of the cell culture reagents were purchased from Invitrogen. The parent pcDNA 3.1(Ϫ) vector was obtained from Invitrogen; pEGFP was from CLONTECH, retroviral Tet-inducible vectors pRevTRE2 and pREvTRE2-dEGFP were from CLONTECH (Palo Alto, CA). All of the restriction enzymes were procured from New England Biolabs (Beverly, MA). The highly purified ␣-thrombin (ϳ2000 units/ mg) and PTX were obtained from Calbiochem. Alexa Fluor 568 phalloidin, DAPI, Oregon Green Bapta-1 acetoxymethylester, Pluronic F127, and the Prolong Antifade kit were purchased from Molecular Probes (Eugene, OR). Anti-G␣ o1/2 antibodies were from Dr. D. Manning (University of Pennsylvania, Philadelphia, PA). 3-Isobutyl-1-methylxanthine, forskolin, and isoproterenol were from Sigma. Electrodes for endothelial monolayer resistance measurements were obtained from Applied Biosciences (Troy, NY). Virions producing the rat G␣ i1 , G␣ i2 , G␣ i3 , and G␣ o1 were obtained from Dr. S. Graber (West Virginia University, Morgantown, WV), whereas those for PAR1 were obtained from Dr. C. Chinni (University of Cambridge, Cambridge, UK). [ 35 S]GTP␥S was from PerkinElmer Life Sciences.
Preparation of Sf9 Membranes-Sf 9 cells were grown at 27°C and at an ambient atmosphere in suspension in a shaking incubator and transfected as described before (21) . Harvested Sf 9 cells were washed with ice-cold 50 mM Tris-HCl buffer, pH 7.4, resuspended in hypotonic 10 mM Tris-HCl buffer, pH 7.4, and homogenized with 10 strokes of a Bio-Homogenizer (BioSpec Products, Inc.) at high speed. The homogenate was centrifuged at 30,000 ϫ g for 20 min at 4°C. The membrane pellet was resuspended in 50 mM Tris-HCl buffer, pH 7.4, containing 10% glycerol and stored in aliquots at Ϫ80°C.
[ 35 
S]GTP␥S Binding Experiments-[
35 S]GTP␥S binding experiments were performed as described previously (22) . Briefly, 10 g of Sf 9 cell membrane protein was diluted in 50 mM Tris-HCl buffer, pH 7.4, containing 5 mM MgCl 2 , 1 mM EGTA, 100 mM NaCl, 0.1 mM dithiothreitol, 10 g/ml saponin, and 1 M GDP and preincubated with TRAP for 15 min at room temperature in a volume of 125 l in a 96-well plate. Then 25 l of [
35 S]GTP␥S diluted 1000-fold in assay buffer was added to the wells, and the assay mixtures were further incubated for 30 min at room temperature. The reactions were terminated by rapid filtration, after which the filters were washed four times with 200 l of 50 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 5 mM MgCl 2 , and 1 mM EGTA. Filter-bound radioactivity was counted in a liquid scintillation spectrometer. Nonspecific [ 35 S]GTP␥S binding was measured in the presence of 100 M GTP␥S and never exceeded 10% of basal binding. Basal [
35 S]GTP␥S binding was estimated in the absence of TRAP. Endothelial Cell Culture-For our studies we used a human dermal microvascular endothelial cell line that was transformed using SV-40 (HMEC-1; obtained from Dr. E. Ades (Centers for Disease Control, Atlanta, GA). The cells were maintained in MCDB 131 medium supplemented with 5% fetal bovine serum, penicillin/streptomycin (5000 units/ml; 5000 g/ml), hydrocortisone (500 g/ml), epidermal growth factor (0.01 g/ml), and L-glutamine (2 mM) in an atmosphere of 95% air, 5% CO 2 at 37°C. The cells were seeded at 1 ϫ 10 5 cells/ml and subcultured after detachment with 0.05% trypsin,/0.5 mM EDTA. All of the studies utilized cell passages 18 -26.
Plasmid Constructs-cDNA minigene constructs were designed as described previously (19) . The C terminus of the G protein-coupled receptor kinase 2 (␤ARK-ct) has been shown to be a potent and specific G␤␥ inhibitor (23) . The ␤ARK-ct construct codes for residues 548 -671 of the rat homolog ␤ARK.
Retroviral minigenes were constructed as follows. The cDNA encoding the last 11 amino acids of human G␣ subunits (G␣ i1/2 and G␣ o ) or the G␣ i1/2 C terminus in random order (G␣ iR ) were synthesized (Great American Gene Company) with newly engineered 5Ј-and 3Ј-ends. The 5Ј-end contained a BamHI site followed by the ribosomebinding consensus sequence (5Ј-GCCGCCACC-3Ј), a methionine (ATG) for translation initiation, and a glycine (GGA) to protect the ribosome-binding site during translation and the nascent peptide against proteolytic degradation. A HindIII site was synthesized at the 3Ј-end immediately following the translational stop codon (TGA). The DNA was brought up in sterile double distilled H 2 O (stock concentration, 100 M). Complimentary DNA was annealed in 1ϫ NE Buffer 3 (50 mM Tris-HCl, 10 mM MgCl 2 , 100 mM NaCl, 1 mM dithiothreitol; New England Biolabs) at 85°C for 10 min and then allowed to cool slowly to room temperature. The annealed cDNA were ligated for 1 h at room temperature into a Tet-inducible retroviral vector pRevTRE2 in murine Maloney tumor virus (CLONTECH) previously cut with BamHI and HindIII. Following ligation, the samples were heated to 65°C for 5 min to deactivate the T4 DNA ligase. The ligation reaction (1 l) was electroporated into 50 l of competent ARI814 cells (BioRad Escherichia coli Pulsar), and the cells were immediately placed into 1 ml of superoptimal catabolite medium (Invitrogen). After 1 h at 37°C, 100 l was spread on LB/ampicillin plates and incubated at 37°C for 12-16 h. To verify that insert was present, several colonies were grown overnight in LB/ampicillin, and their plasmid DNA was purified (Qiagen SpinKit). The plasmid DNA was digested with NcoI (New England Biolabs, Inc.) for 1 h at 37°C and run on a 1.5% (3:1) agarose gel. Vector alone produced one band (6.5 kb), whereas vector with insert resulted in two bands (5.1 and 1.4 kb). DNA with the correct pattern was sequenced (Northwestern University Biotechnology Center) to confirm the appropriate sequence.
For optimal results, the retroviral vectors were packaged using the pantropic GP-293 cell line (CLONTECH) with vesicular stomatitis virus glycoprotein, an envelope glycoprotein from the vesicular stomatitis virus. As a control, we used the enhanced GFP inserted into the parental vector (pRevTRE2-dEGFP; CLONTECH). Retroviral minigenes were generated by infecting the packaging cells GP-293 with pRevTRE2 minigenes and vesicular stomatitis virus glycoprotein using Effectene reagent according to instructions from the manufacturer (CLON-TECH). 12-16 h later, the medium was replaced by 5 ml of fresh medium/10-cm dish, and the virus produced by the cells was collected 2-3 days post-transfection by filtration through 0.45-m cellulose acetate filters and stored in aliquots at Ϫ80°C. The virus titer reached 4 ϫ 10 6 plaque-forming units/ml. Transfection and Infections-For pcDNA-based minigenes, HMECs were transiently transfected with DNA (2 g/100-mm plate or 500 ng/well for a 6-well plate) using Effectene transfection reagent (Qiagen). To monitor the efficiency of transfection, the cells were co-transfected with pEGFP, a plasmid vector containing enhanced green fluorescent protein to monitor stress fiber formation, or DsRED (CLONTECH), a plasmid vector containing red fluorescent protein for [Ca 2ϩ ] i imaging. After 3 h, the medium was changed, and fresh medium was added. After 48 h, the cells co-transfected with the fluorescent proteins were replated onto coverslips and analyzed using a fluorescent microscope to determine the efficiency of transfection. Adenylyl cyclase and HMEC monolayer permeability experiments were performed using cells infected with retroviral minigenes. HMECs were infected with retroviral minigene virus (2 ϫ 10 6 plaque-forming units/well for 6-well plate). The expression of the minigene peptide was induced 24 h after viral infection with 2 g/ml doxycyclin, and the experiments were performed 24 h after induction. Use of retroviral minigenes led to ϳ100% transfection efficiency. This was confirmed using infection of the pRevTRE2-dEGFP vector, which exhibited expression of GFP in virtually every cell (data not shown).
Western Blot Analysis-Endothelial cell lysates were resolved by SDS-PAGE on a 10 -20% separating gel under reducing conditions. For immunoblotting analysis, the proteins were transferred to polyvinylidene difluoride membranes using standard semi-dry transfer method. The membranes were blocked with 5% dry milk in phosphate-buffered saline, 0.05% Tween 20 for 1 h at room temperature. The membranes were incubated with indicated primary antibody (diluted in blocking buffer) at 4°C overnight. Following washes, the membranes were incubated at room temperature with peroxidaselabeled secondary antibodies and detected using luminol-based chemiluminescent detection system (LumiGLO, Kirkegaard and Perry Laboratories, Gaithersburg, MD).
cAMP Assay-HMECs were seeded onto 6-well plates at 1 ϫ 10 5 cells/well 24 h before transfection. The cells were transfected with retroviral minigene constructs, and 24 h before the assay, the cells were seeded into a 24-well plate. Thereafter, the cells were washed once with serum-free medium containing 1 mM 3-isobutyl-1-methylxanthine, a phosphodiesterase inhibitor, and further incubated for 20 min in 500 l of serum-free medium containing 1 mM 3-isobutyl-1-methylxanthine. After the preincubation, 50 l of preincubation medium supplemented with forskolin (final concentration, 10 M) was added to each well. To detect the inhibitory effect, 100 nM thrombin or 10 M NECA was added along with forskolin. Basal cAMP accumulation was measured in the absence of forskolin and compounds. The reactions were terminated by the addition of 100 l of 1 N HCLO 4 . The samples were frozen and thawed, and 200 l of KOH/K 3 PO 4 (0.5 M, pH 13.5) was added to neutralize the samples (final pH, 7.4). After formation of the KClO 4 precipitate (30 min at 4°C), the plates were centrifuged (10 min at 650 ϫ g, 4°C). The amount of cAMP in each well was determined with a commercial 125 I-labeled cAMP radioimmunoassay kit (Biomedical Technologies Inc., Stoughton, MA).
[Ca 2ϩ ] i Response-In single cell fluorescence measurements, the DsRED (CLONTECH) fluorescence reporter gene was used to confirm the transfected cells. HMECs were transfected with pcDNA-G i1/2 , pcDNA-G o1 , or pcDNA-G iR minigene DNA and with or without ␤ARK-ct DNA along with DsRED. After 48 h, the cells were transferred to coverslips at a low confluency in a 24-well plate and allowed to adhere for at least 2 h. The medium was aspirated, and each coverslip was incubated at 37°C for 30 min in 0.5 ml of loading buffer (20 mM Hepes, pH 7.4, 130 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgSO 4 , 0.83 mM Na 2 HPO 4 , 0.17 mM NaH 2 PO 4 , 1 mg/ml bovine serum albumin, 25 mM mannose) containing 0.1% (v/v) Pluronic F127 and 10 M Oregon Green Bapta-1 acetoxymethyl ester. The cells were washed twice with and incubated in Ca 2ϩ buffer (10 mM Hepes, pH 7.4, 140 mM NaCl, 5 mM KCl, 0.5 mM CaCl 2 , 0.55 mM MgCl 2 ). The coverslips were placed in the chamber that was mounted on the stage of an upright microscope. The experiment was performed at room temperature. The transfected cells were identified using a green filter by observing DsRED fluorescence. The basal conditions were established for 40 s before addition of thrombin (ϳ70 nM). Recordings (exposure time) were made every 10 s and continued for 170 s after stimulation with thrombin. The images were quantified using the NIH Image Program.
Immunofluorescent Microscopy-As a marker for transfected cells, the pEGFP plasmid containing the gene for enhanced green fluorescent protein was transiently co-transfected together with minigene constructs as described above. HMECs were grown on gelatin-coated coverslips, serum-starved for 24 h, washed with HBSS, and fixed with 4% paraformaldehyde. The coverslips were washed three times for 5 min in 100 mM glycine in HBSS to quench and remove the fixative followed by three washes for 10 min in HBSS. The cells were permeabilized with 0.1% Triton X-100 and washed three times for 10 min in HBSS. Thereafter, the cells were incubated for 90 min at room temperature with 200 nM Alexa Fluor 568-phallodin to visualize polymerized F-actin. The coverslips were washed three times for 10 min in HBSS and labeled with 1 g/ml DAPI for 30 min to visualize the nucleus. The coverslips were finally washed three times for 10 min in HBSS and mounted on a drop of ProLong Antifade mounting medium (Molecular Probes). The cells were observed with a Zeiss 510 laser scanning confocal microscope (New York, NY) using 364-, 488-, and 568-nm excitation laser lines to detect DAPI (BP 385-470 nm emission), fluorescein isothiocyanate/Alexa 488 (BP505-550 emission), and rhodamine/Alexa 568 fluorescence (LP585 emission) with the ϫ63 1.4 NA water immersion objective. The acquired images were later assembled using Adobe Photoshop, MS PowerPoint, and Macromedia Freehand image processing software.
Transendothelial Electrical Resistance Assay-Endothelial cell retraction measured in real time in response to thrombin was measured as described before (24) . HMECs were infected with retroviral minigene constructs and seeded on gelatin-coated gold electrodes (4.9 ϫ 10 4 cm 2 ) and grown to confluence. The small and larger counter electrodes were connected to a phase-sensitive lock-in amplifier. A constant current of 1 A was applied by a 1 V, 4000 Hz AC signal connected serially to 1 M⍀ resistor between the small and large counter electrodes. The voltage between the small electrode and the large counter electrode was monitored by a lock-in amplifier, stored, and processed by a personal computer. The same computer controlled the output of the amplifier and switched the measurement to different electrodes in the course of the experiment. Prior to the experiments, the monolayers were washed two times with serum-free medium and incubated for 2 h in 1% serumsupplemented medium.
Data Analysis-The data were analyzed using GraphPad Prism 2.01 (GraphPad Software, San Diego, CA). Statistical comparisons were made using a two-tailed Student's t test. The experimental values were considered significant at p Ͻ 0.05.
RESULTS

Coupling of PAR1 to G o1 Proteins in Sf9 Membranes-
Thrombin is known to couple to multiple G proteins including G i , G q , and G 12/13 proteins (25) . Activation of the thrombin receptor results in initiating an array of signal transduction pathways such as phosphatidylinositol hydrolysis, mobilization of Ca 2ϩ stores, induction of stress fiber formation, and activation of mitogen-activated protein kinase (1, 5) . Some signaling pathways regulated by thrombin have been shown to be sensitive to PTX, e.g. intracellular calcium release, activation of Na ϩ /H ϩ exchanger, arachidonic acid release, induction of PAR1 gene expression, von Willebrand Factor release, and endothelial relaxation (12) (13) (14) (15) (16) (17) (18) . PTX abolishes the interaction between receptors and all members of the G i subfamily (except G z ) through ADP-ribosylation of the Cys 351 residue in the C terminus of the G␣ subunit. The effect of PTX has often been attributed to G i proteins, because G o proteins are generally believed to play a role in the brain, where it constitutes about 1% of the total protein content (26) .
To determine whether PAR1, the most characterized thrombin receptor, can potentially couple to G o proteins, we expressed this receptor in Sf 9 cells along with G␣ o1 , G␤ 1 and G␥ 2 , and measured TRAP-stimulated [
35 S]GTP␥S binding to membranes prepared from these cells. As a negative control, we co-expressed PAR1, G␤ 1 , and G␥ 2 (but not G␣ o ) in Sf 9 cells. Fig  1 shows could not conclude whether the lower stimulation level by G␣ i ␤ 1 ␥ 2 reflected a lower coupling efficiency or a lower expression of receptor or G protein.
Presence of G o Proteins in HMECs-Because we demonstrated coupling of PAR1 to G o1 proteins when co-expressed in Sf 9 cells, we next investigated the presence of G o proteins in HMECs. HMEC lysates were subjected to SDS-PAGE and blotted onto polyvinylidene difluoride membranes. The presence of G o proteins was detected with an antibody that recognizes both G o1 and G o2 proteins, but not G i proteins (8) . Fig. 2 shows that HMECs contain G o proteins. This unexpected finding led us to further investigate the coupling of G o proteins to thrombin receptors in HMECs.
Inhibition of Adenylyl Cyclase-To determine whether G i or G o proteins are involved in thrombin-mediated inhibition of adenylyl cyclase, HMECs were infected with pRevTRE2-G i1/2 or pRevTRE2-G o1 minigenes. We could not demonstrate thrombin-mediated inhibition of adenylyl cyclase after either forskolin or isoproterenol stimulation of HMEC. This might be attributable to a different source of HMECs than used previously (27) . We tested several different conditions including preincubation with thrombin before challenging the cells with forskolin and thrombin: leaving out thrombin in either the preincubation or incubation step (to eliminate receptor desensitization), elimination of 3-isobutyl-1-methylxanthine (to reduce protein kinase A effects), different concentrations of forskolin, or variation of the incubation or preincubation times. Under none of these experimental conditions did we demonstrate inhibition of forskolin-or isoproterenol-stimulated cAMP formation by thrombin (data not shown). Indeed, thrombin-mediated inhibition of adenylyl cyclase has only been reported in specific endothelial cell lines (28 -31) .
To verify whether our experimental conditions were sufficient to measure inhibition of adenylyl cyclase activity, we measured it in a CHO cell line that stably expressed A 3 adenosine receptors, which couple preferentially to G i/o proteins. Our results show that stimulation of A 3 adenosine receptors inhibited adenylyl cyclase in CHO cells (Fig. 3) . When these CHO cells were infected with retroviral minigene viruses, and the expression of the 11-amino acid C-terminal peptide of G i1/2 or G o1 proteins was induced 24 h before the experiment, this inhibitory action of A 3 adenosine receptors on cAMP formation was blocked almost completely (Fig. 3) . Infection of a control virus (pRevTRE2-G iR ) that encodes a peptide based on the C-terminal sequence of G i1/2 in random order did not have an effect on the inhibition of cAMP formation through A 3 adenosine receptors. This blockade of inhibition was observed in CHO cells infected with pRevTRE2-G i1/2 or pRevTRE2-G o1 minigene viruses, indicating that both proteins can couple to A 3 adenosine receptors to inhibit adenylyl cyclase.
Stimulation of Intracellular Calcium Release-Previously, we have shown that thrombin-mediated stimulation of [Ca 2ϩ ] i was blocked in HMECs transfected with pcDNA-G q , but not pcDNA-G i1/2 minigene vectors, which eliminated a role for G i proteins in this signaling event of thrombin receptors (1) . In this study, we loaded HMECs transfected with pcDNA-G i1/2 , pcDNA-G o1 , or pcDNA-G iR minigene vectors with Oregon Green Bapta-1 for 30 min and measured the thrombin-induced [Ca 2ϩ ] i in single cells. Fig 4 shows that HMECs transfected with pcDNA-G o1 minigene vector showed a marked reduction in their calcium response to thrombin, but HMECs transfected with pcDNA-G i1/2 or pcDNA-G iR minigene vectors were unaffected. This means that G o proteins, but not G i proteins, play a role in the thrombin-stimulated [Ca 2ϩ ] i increase. To further delineate the mechanism whereby G o proteins participate in thrombin-mediated calcium signaling pathways, we used a scavenger of G␤␥, the ␤-adrenergic receptor kinase C-terminal vector (23) , which would allow us to differentiate the role of the G␣ versus G␤␥ subunits of G o . We co-transfected ␤ARK-ct DNA along with minigene DNA and measured [Ca 2ϩ ] i (Fig. 5) . ␤ARK-ct expression in G iR minigene transfected cells led to the same amount of inhibition of [Ca 2ϩ ] i as in G o minigene transfected cells, suggesting that G o ␤␥ is involved in activation of PLC␤. As expected, the addition of the ␤ARK-ct with the G q minigene together had no further effect on [Ca 2ϩ ] i , which is through the G␣ subunit of G q . Thus, G o , but not G i , activation by PAR1 in HMEC cells leads to G ␤␥ activation of PLC␤. Because G i can couple to PAR1 when overexpressed in Sf 9 cells, these data provide evidence of a cell type-specific coupling of PAR1 to PLC␤.
Stimulation of Stress Fiber Formation-The unexpected finding that G o proteins are involved in the calcium response to thrombin in HMECs led us to further investigate the importance of G o proteins in downstream signaling events. It has already been shown that thrombin-mediated F-actin stress fiber formation can in part be regulated by [Ca 2ϩ ] i (32) . Therefore, HMECs were co-transfected with pcDNA-GFP and pcDNA-G i1/2 or pcDNA-G o1 minigene vectors, and thrombininduced stress fiber formation was monitored 48 h after transfection. The cells were serum-starved for 24 h prior to thrombin stimulation, permeabilized, and stained for F-actin with Alexa 568-phalloidin, and their nuclei were stained with DAPI. Transfected cells were distinguished from untransfected cells by detecting GFP fluorescence. Thrombin-stimulated stress fiber formation is blocked almost completely in G o1 minigene transfected cells. In contrast, the presence of the G i1/2 minigene did not change the level of thrombin-stimulated stress fiber formation as compared with cells transfected with the G iR minigene (Fig. 6, section II) .
If G o is required for thrombin-induced stress fiber formation, then pertussis toxin, which ADP-ribosylates G o as well as G i ␣ subunit, should inhibit stress fiber formation. Treatment of HMECs with pertussis toxin (100 ng/ml) resulted in a strong blockade of thrombin-induced stress fiber formation (Fig. 6,  section III) . Together, these data clearly show the involvement of G o proteins, but not G i proteins, in F-actin stress fiber formation.
Transendothelial Electrical Resistance Assay-Thrombininduced stress fiber formation may lead to cellular contraction and disruption of the endothelial monolayer. This leads to an increase in permeability of the endothelial monolayer and may have physiological significance in inflammation and wound healing. To check the involvement of G o proteins in endothelial permeability, we measured transendothelial electrical resistance on microelectrodes. Confluent HMEC monolayers were seeded onto electrodes and challenged with thrombin. When thrombin induces cell rounding through modification of the cellular cytoskeleton, a transient decrease in resistance can be measured. Fig. 7 shows the thrombin-induced decrease in electrical resistance on electrodes covered with cells infected with pRevTRE2 or pRevTRE2-G iR virus expressing the G i random sequence in all of the cells. Similarly a decrease in permeability was observed when HMECs were infected with pRevTRE2-G i1/2 minigene virus. However, thrombin treatment in HMECs infected with pRevTRE2-G o1 minigene virus or pretreated with PTX (100 ng/ml) resulted in a dramatic blockade of the thrombin-induced transendothelial electrical resistance change compared with either G iR or G i1/2 minigene transfected HMECs. ] i measurements were performed as described for Fig. 4 . The data are represented as percentages of inhibition compared with the control condition in which HMEC cells were transfected with the G iR minigene, which is set at 100% and taken from the peak signal at 90 s. The data represent the mean fold increase in fluorescence Ϯ S.E. recorded in 14 -26 cells. Each experimental calcium signal was significantly lower than G iR transfected cells (paired Student's t test; p Ͻ 0.001). (26) . Although the role of G␣ o proteins had been somewhat obscure, several reports now indicate distinct roles and effectors for these G␣ subunits, which share about 80% amino acid identity with G i proteins. Novel effectors or regulators such as Rap1GAP, VMAT2, RGS14, or Pcp2 have been described that G o specifically or differentially targets compared with G i proteins (9 -11, 33, 34) .
PTX-mediated ADP-ribosylation of G i or G o proteins inhibits their interaction with G protein-coupled receptors, and several thrombin-mediated effects have been shown to be sensitive to PTX (12, 13, 17) , such as stimulation of PAR1 gene expression (18) , NO release (15), endothelial relaxation (14) , Ca 2ϩ influx, and release of tissue plasminogen activator and Von Willebrand factor (16). To determine whether G o proteins serve a specific role in the signaling pathways of thrombin receptors in HMECs, we investigated whether PAR1 has the potential to activate G o proteins in vitro. TRAP stimulation of PAR1 induced a 7-fold increase in [
35 S]GTP␥S binding to Sf 9 membranes co-expressing PAR1 and the G␣ o1 ␤ 1 ␥ 2 heterotrimer. This stimulation of [
35 S]GTP␥S binding was significantly higher than in membranes expressing PAR1 along with the G␤ 1 ␥ 2 dimer. We also found in similar experiments that TRAP stimulates [
35 S]GTP␥S to Sf 9 membranes co-expressing PAR1 and G i1 , G i2 , or G i3 heterotrimers (data not shown). Because no radioligands are commercially available to determine the level of receptors, we could not distinguish whether PAR1 couples preferentially to a specific G protein subtype. Hence, we conclude that PAR1 has the ability to couple to and activate G o proteins, as well as G i proteins.
Although PAR1 is able to couple to G i in Sf 9 cells overexpressing either G i1 , G i2 , or G i3 , in HMECs, there was no inhibition of adenylyl cyclase by thrombin under a variety of conditions. In a CHO cell line that stably expressed A 3 adenosine receptors, a 30% inhibition of forskolin-stimulated cAMP formation could be observed, and this effect was blocked by infec- The production of the C-terminal peptides was induced using 2 g/ml doxycyclin. After serum deprivation, the cells were stimulated with 25 nM thrombin, and changes in transendothelial electrical resistance were monitored in real time. A representative from at least three experiments is shown. Statistical analysis was performed with the peak values. The peak values from PTX-treated HMECs were significantly smaller than peak values from cells infected with pRevTRE2-G i1/2 minigene virus. A similar reduction was observed in cells infected with pRevTRE2-G o1 virus. The cells infected with pRevTRE2-G iR showed a smaller peak value than control, but our results indicate that G o proteins may play a prominent role in disruption of the endothelial monolayer (paired Student's t test; p Ͻ 0.05).
tion of either pRevTRE2-G i1/2 or pRevTRE2-G o1 minigene virus. Taken together, these findings suggest that thrombin receptors do not use G i or G o proteins to inhibit adenylyl cyclase in HMECs. Interestingly, PAR1 does couple to G i to regulate PAR-1 gene expression in HMEC cells (18) , endothelial albumin endocytosis (35) , or endothelial proliferation. 2 Next, we showed that G o proteins are expressed in HMECs. This finding further indicates that G o proteins may play a role in the signaling of thrombin receptors in HMECs. Because calcium signaling has been shown to be sensitive to PTX in several cell lines, we wanted to verify whether transfection of minigene vectors encoding the C-terminal sequence of G i1/2 or G o1 proteins could block thrombin-stimulated intracellular calcium mobilization. Previously, we have shown that the G q minigene vectors, but not the G i1/2 minigene vectors can block thrombin-stimulated phosphatidylinositol hydrolysis and intracellular calcium mobilization (1) . In addition, we demonstrated that a minigene vector encoding the G q C-terminal peptide in which the last two residues were mutated could not block these effects. These findings demonstrated that G␣ Cterminally based minigenes can specifically block G protein families. We showed in HMEC that G o minigenes caused a significant reduction in [Ca 2ϩ ] i response to thrombin compared with G i1/2 or G iR minigenes. These results indicate that G o , but not G i , serves to couple thrombin receptors to calcium signaling. This Ca 2ϩ transient is mediated by G␤␥ activation of PLC␤, because a similar inhibition was induced by transfection with a scavenger of G␤␥ signaling, the ␤ARK-ct peptide, and their effects were not additive. Thus, there is a cell-specific lack of coupling of G i ␤␥ to PLC␤.
To further demonstrate the importance of G o proteins in signal transduction pathways downstream from calcium events, we measured thrombin-stimulated stress fiber formation in HMECs transfected with minigene vectors or pretreated with PTX. Stress fiber formation has been shown to depend on a number of signaling events, including intracellular calcium release and/or activation of Ca 2ϩ -dependent protein kinase C (32, 36) . Thrombin-induced stress fiber formation was blocked in PTX-pretreated cells as well as in cells transfected with pcDNA-G o1 minigene vector but not in cells transfected with pcDNA-G i1/2 minigene vector, indicating the involvement of G o proteins, but not G i proteins, in this signaling event.
Formation of stress fibers often leads to cell rounding, which, in the case of endothelial cells, disrupts the endothelial monolayer. Hence, we measured endothelial monolayer permeability, a physiological response downstream of stress fiber formation. Thrombin induced a decrease in transendothelial electrical resistance, and this effect was blocked in cells pretreated with PTX. The cells infected with the pRevTRE2-G o1 minigene virus also exhibited a muted thrombin response. The cells infected with the control virus pRevTRE2-G iR had a normal response to thrombin, whereas the cells infected with pRevTRE2-G i1/2 demonstrated a slightly reduced response. Hence, we showed that G o proteins play an important role in the signaling of thrombin receptors distinct from G i proteins, and we confirmed its involvement in different levels of the signaling cascade from calcium mobilization to stress fiber formation and endothelial barrier dysfunction.
In conclusion, we have demonstrated a novel role for G o proteins in the signal transduction of thrombin receptors in HMECs in which they regulate calcium signaling and cytoskeletal rearrangements. In addition, we have shown that the minigene approach can be used to dissect out the effects of pertussis toxin and determine whether they are mediated by G i or G o proteins.
